Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting

RecruitingOBSERVATIONAL
Enrollment

1,300

Participants

Timeline

Start Date

August 15, 2020

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2025

Conditions
Lung Cancer PatientsCaregivers
Interventions
OTHER

There are no interventions in this study. All participants complete online surveys.

There are no interventions in this study. All participants complete online surveys.

Trial Locations (1)

20814

RECRUITING

LUNGevity Foundation, Bethesda

All Listed Sponsors
collaborator

Amgen

INDUSTRY

collaborator

AstraZeneca

INDUSTRY

collaborator

Blueprint Medicines Corporation

INDUSTRY

collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

G1 Therapeutics, Inc.

INDUSTRY

collaborator

Genentech, Inc.

INDUSTRY

collaborator

Janssen, LP

INDUSTRY

collaborator

Jazz Pharmaceuticals

INDUSTRY

collaborator

Merck Sharp & Dohme LLC

INDUSTRY

collaborator

Novartis

INDUSTRY

collaborator

Takeda

INDUSTRY

lead

LUNGevity Foundation

OTHER